Biologics Market (2025 - 2030) Size, Share & Trends Analysis Report By Source (Microbial, Mammalian), By Product (MABs, Recombinant Proteins, Antisense & RNAi), By Disease Category, By Manufacturing, By Region, And Segment Forecasts

Market Segmentation

• Biologics Source Outlook (Revenue, USD Billion, 2018 - 2030)
  • Microbial
  • Mammalian
  • Others
• Biologics Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Monoclonal Antibodies 
    • MABs by Application
      • Diagnostic
        • Biochemical Analysis
        • Diagnostic Imaging
      • Therapeutic
        • Direct MAB Agents
        • Targeting MAB Agents
      • Protein Purification
      • Others
    • MABs by Type
      • Murine
      • Chimeric
      • Humanized
      • Human
      • Others
  • Vaccines
  • Recombinant Proteins
  • Antisense & RNAi Therapeutics
  • Others
• Biologics Disease Category Outlook (Revenue, USD Billion, 2018 - 2030)
  • Oncology
    • By Product
      • MABs
      • Vaccines
      • Recombinant Proteins
      • Antisense & RNAi Therapeutics
      • Others (Certain products under trials related to blood products etc)
  • Infectious Diseases
  • By Product
    • Vaccines
    • MABs
    • Antisense & RNAi Therapeutics
    • Recombinant Proteins
    • Others
  • Immunological Disorders
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others
• Biologics Manufacturing Outlook (Revenue, USD Billion, 2018 - 2030)
  • Outsourced
  • In-house
• Biologics Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • North America Biologics Market, By Source
      • Microbial
      • Mammalian
      • Others
    • North America Biologics Market, By Product
      • Monoclonal Antibodies 
        • MABs by Application
          • Diagnostic
            • Biochemical Analysis
            • Diagnostic Imaging
          • Therapeutic
            • Direct MAB Agents
            • Targeting MAB Agents
          • Protein Purification
          • Others
        • MABs by Type
          • Murine
          • Chimeric
          • Humanized
          • Human
          • Others
      • Vaccines
      • Recombinant Proteins
      • Antisense & RNAi Therapeutics
      • Others
    • North America Biologics Market, By Manufacturing
      • Oncology
        • By Product
          • MABs
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others (Certain products under trials related to blood products etc)
      • Infectious Diseases
      • By Product
        • Vaccines
        • MABs
        • Antisense & RNAi Therapeutics
        • Recombinant Proteins
        • Others
      • Immunological Disorders
      • Cardiovascular Disorders
      • Hematological Disorders
      • Others
    • North America Biologics Market, By Disease Category
      • Outsourced
      • In-house
    • U.S.
      • U.S. Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • U.S. Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • U.S. Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • U.S. Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Canada
      • Canada Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Canada Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Canada Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Canada Biologics Market, By Disease Category
        • Outsourced
        • In-house
  • Europe
    • Europe Biologics Market, By Source
      • Microbial
      • Mammalian
      • Others
    • Europe Biologics Market, By Product
      • Monoclonal Antibodies 
        • MABs by Application
          • Diagnostic
            • Biochemical Analysis
            • Diagnostic Imaging
          • Therapeutic
            • Direct MAB Agents
            • Targeting MAB Agents
          • Protein Purification
          • Others
        • MABs by Type
          • Murine
          • Chimeric
          • Humanized
          • Human
          • Others
      • Vaccines
      • Recombinant Proteins
      • Antisense & RNAi Therapeutics
      • Others
    • Europe Biologics Market, By Manufacturing
      • Oncology
        • By Product
          • MABs
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others (Certain products under trials related to blood products etc)
      • Infectious Diseases
      • By Product
        • Vaccines
        • MABs
        • Antisense & RNAi Therapeutics
        • Recombinant Proteins
        • Others
      • Immunological Disorders
      • Cardiovascular Disorders
      • Hematological Disorders
      • Others
    • Europe Biologics Market, By Disease Category
      • Outsourced
      • In-house
    • Germany
      • Germany Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Germany Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Germany Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Germany Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • U.K.
      • U.K. Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • U.K. Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • U.K. Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • U.K. Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • France
      • France Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • France Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • France Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • France Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Italy
      • Italy Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Italy Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Italy Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Italy Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Spain
      • Spain Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Spain Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Spain Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Spain Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Denmark
      • Denmark Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Denmark Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Denmark Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Denmark Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Sweden
      • Sweden Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Sweden Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Sweden Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Sweden Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Norway
      • Norway Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Norway Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Norway Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Norway Biologics Market, By Disease Category
        • Outsourced
        • In-house
  • Asia Pacific
    • Asia Pacific Biologics Market, By Source
      • Microbial
      • Mammalian
      • Others
    • Asia Pacific Biologics Market, By Product
      • Monoclonal Antibodies 
        • MABs by Application
          • Diagnostic
            • Biochemical Analysis
            • Diagnostic Imaging
          • Therapeutic
            • Direct MAB Agents
            • Targeting MAB Agents
          • Protein Purification
          • Others
        • MABs by Type
          • Murine
          • Chimeric
          • Humanized
          • Human
          • Others
      • Vaccines
      • Recombinant Proteins
      • Antisense & RNAi Therapeutics
      • Others
    • Asia Pacific Biologics Market, By Manufacturing
      • Oncology
        • By Product
          • MABs
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others (Certain products under trials related to blood products etc)
      • Infectious Diseases
      • By Product
        • Vaccines
        • MABs
        • Antisense & RNAi Therapeutics
        • Recombinant Proteins
        • Others
      • Immunological Disorders
      • Cardiovascular Disorders
      • Hematological Disorders
      • Others
    • Asia Pacific Biologics Market, By Disease Category
      • Outsourced
      • In-house
    • Japan
      • Japan Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Japan Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Japan Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Japan Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • China
      • China Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • China Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • China Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • China  Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • India
      • India Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • India Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • India Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • India Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Australia
      • Australia Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Australia Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Australia Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Australia Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • South Korea
      • South Korea Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • v Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • South Korea Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • South Korea Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Thailand
      • Thailand  Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Thailand Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Thailand Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Thailand Biologics Market, By Disease Category
        • Outsourced
        • In-house
  • Latin America
    • Latin America Biologics Market, By Source
      • Microbial
      • Mammalian
      • Others
    • Latin America Biologics Market, By Product
      • Monoclonal Antibodies 
        • MABs by Application
          • Diagnostic
            • Biochemical Analysis
            • Diagnostic Imaging
          • Therapeutic
            • Direct MAB Agents
            • Targeting MAB Agents
          • Protein Purification
          • Others
        • MABs by Type
          • Murine
          • Chimeric
          • Humanized
          • Human
          • Others
      • Vaccines
      • Recombinant Proteins
      • Antisense & RNAi Therapeutics
      • Others
    • Latin America Biologics Market, By Manufacturing
      • Oncology
        • By Product
          • MABs
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others (Certain products under trials related to blood products etc)
      • Infectious Diseases
      • By Product
        • Vaccines
        • MABs
        • Antisense & RNAi Therapeutics
        • Recombinant Proteins
        • Others
      • Immunological Disorders
      • Cardiovascular Disorders
      • Hematological Disorders
      • Others
    • Latin America Biologics Market, By Disease Category
      • Outsourced
      • In-house
    • Brazil
      • Brazil Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Brazil Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Brazil Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Brazil Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Mexico
      • Mexico Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Mexico Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Mexico Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Mexico  Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Argentina
      • Argentina Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Argentina  Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Argentina Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Argentina Biologics Market, By Disease Category
        • Outsourced
        • In-house
  • Middle East and Africa (MEA)
    • MEA Biologics Market, By Source
      • Microbial
      • Mammalian
      • Others
    • MEA Biologics Market, By Product
      • Monoclonal Antibodies 
        • MABs by Application
          • Diagnostic
            • Biochemical Analysis
            • Diagnostic Imaging
          • Therapeutic
            • Direct MAB Agents
            • Targeting MAB Agents
          • Protein Purification
          • Others
        • MABs by Type
          • Murine
          • Chimeric
          • Humanized
          • Human
          • Others
      • Vaccines
      • Recombinant Proteins
      • Antisense & RNAi Therapeutics
      • Others
    • MEA Biologics Market, By Manufacturing
      • Oncology
        • By Product
          • MABs
          • Vaccines
          • Recombinant Proteins
          • Antisense & RNAi Therapeutics
          • Others (Certain products under trials related to blood products etc)
      • Infectious Diseases
      • By Product
        • Vaccines
        • MABs
        • Antisense & RNAi Therapeutics
        • Recombinant Proteins
        • Others
      • Immunological Disorders
      • Cardiovascular Disorders
      • Hematological Disorders
      • Others
    • MEA Biologics Market, By Disease Category
      • Outsourced
      • In-house
    • South Africa
      • South Africa Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • South Africa Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • South Africa Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • South Africa Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Saudi Arabia
      • Saudi Arabia Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Saudi Arabia Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Saudi Arabia Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Saudi Arabia  Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • UAE
      • UAE Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • UAE Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • UAE Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • UAE Biologics Market, By Disease Category
        • Outsourced
        • In-house
    • Kuwait
      • Kuwait Biologics Market, By Source
        • Microbial
        • Mammalian
        • Others
      • Kuwait Biologics Market, By Product
        • Monoclonal Antibodies 
          • MABs by Application
            • Diagnostic
              • Biochemical Analysis
              • Diagnostic Imaging
            • Therapeutic
              • Direct MAB Agents
              • Targeting MAB Agents
            • Protein Purification
            • Others
          • MABs by Type
            • Murine
            • Chimeric
            • Humanized
            • Human
            • Others
        • Vaccines
        • Recombinant Proteins
        • Antisense & RNAi Therapeutics
        • Others
      • Kuwait Biologics Market, By Manufacturing
        • Oncology
          • By Product
            • MABs
            • Vaccines
            • Recombinant Proteins
            • Antisense & RNAi Therapeutics
            • Others (Certain products under trials related to blood products etc)
        • Infectious Diseases
        • By Product
          • Vaccines
          • MABs
          • Antisense & RNAi Therapeutics
          • Recombinant Proteins
          • Others
        • Immunological Disorders
        • Cardiovascular Disorders
        • Hematological Disorders
        • Others
      • Kuwait Biologics Market, By Disease Category
        • Outsourced
        • In-house

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance